BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 29129827)

  • 1. Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.
    Weng LC; Preis SR; Hulme OL; Larson MG; Choi SH; Wang B; Trinquart L; McManus DD; Staerk L; Lin H; Lunetta KL; Ellinor PT; Benjamin EJ; Lubitz SA
    Circulation; 2018 Mar; 137(10):1027-1038. PubMed ID: 29129827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of risk factor burden and genetic predisposition with the 10-year risk of atrial fibrillation: observations from a large prospective study of 348,904 participants.
    Zhang J; Chen G; Wang C; Wang X; Qian ZM; Cai M; Vaughn MG; Bingheim E; Li H; Gao Y; Lip GYH; Lin H
    BMC Med; 2023 Mar; 21(1):88. PubMed ID: 36882748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study.
    Rahman F; Yin X; Larson MG; Ellinor PT; Lubitz SA; Vasan RS; McManus DD; Magnani JW; Benjamin EJ
    Hypertension; 2016 Sep; 68(3):597-605. PubMed ID: 27512109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Dewland TA; Soliman EZ; Yamal JM; Davis BR; Alonso A; Albert CM; Simpson LM; Haywood LJ; Marcus GM
    Circ Arrhythm Electrophysiol; 2017 Dec; 10(12):. PubMed ID: 29212812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study).
    Rienstra M; Sun JX; Magnani JW; Sinner MF; Lubitz SA; Sullivan LM; Ellinor PT; Benjamin EJ
    Am J Cardiol; 2012 Feb; 109(4):533-7. PubMed ID: 22100030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study.
    Hobbelt AH; Siland JE; Geelhoed B; Van Der Harst P; Hillege HL; Van Gelder IC; Rienstra M
    Europace; 2017 Feb; 19(2):226-232. PubMed ID: 28175276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.
    Lloyd-Jones DM; Wang TJ; Leip EP; Larson MG; Levy D; Vasan RS; D'Agostino RB; Massaro JM; Beiser A; Wolf PA; Benjamin EJ
    Circulation; 2004 Aug; 110(9):1042-6. PubMed ID: 15313941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study.
    Staerk L; Wang B; Lunetta KL; Helm RH; Ko D; Sherer JA; Ellinor PT; Lubitz SA; McManus DD; Vasan RS; Benjamin EJ; Trinquart L
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29138179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation and the risk of myocardial infarction.
    Soliman EZ; Safford MM; Muntner P; Khodneva Y; Dawood FZ; Zakai NA; Thacker EL; Judd S; Howard VJ; Howard G; Herrington DM; Cushman M
    JAMA Intern Med; 2014 Jan; 174(1):107-14. PubMed ID: 24190540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.
    Staerk L; Wang B; Preis SR; Larson MG; Lubitz SA; Ellinor PT; McManus DD; Ko D; Weng LC; Lunetta KL; Frost L; Benjamin EJ; Trinquart L
    BMJ; 2018 Apr; 361():k1453. PubMed ID: 29699974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between Alcohol Intake and Genetic Predisposition With Atrial Fibrillation Risk in a National Biobank.
    Halford JL; Weng LC; Choi SH; Jurgens SJ; Morrill VN; Khurshid S; Trinquart L; Benjamin EJ; Ellinor PT; Lubitz SA
    Circ Genom Precis Med; 2020 Dec; 13(6):e003111. PubMed ID: 33156697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Functional Status to Risk of Development of Atrial Fibrillation.
    Ramkumar S; Yang H; Wang Y; Nolan M; Negishi K; Sanders P; Marwick TH
    Am J Cardiol; 2017 Feb; 119(4):572-578. PubMed ID: 27956001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulse pressure and risk of new-onset atrial fibrillation.
    Mitchell GF; Vasan RS; Keyes MJ; Parise H; Wang TJ; Larson MG; D'Agostino RB; Kannel WB; Levy D; Benjamin EJ
    JAMA; 2007 Feb; 297(7):709-15. PubMed ID: 17312290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation.
    Hyman MC; Levin MG; Gill D; Walker VM; Georgakis MK; Davies NM; Marchlinski FE; Damrauer SM
    Hypertension; 2021 Feb; 77(2):376-382. PubMed ID: 33390040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times: Application in the Framingham Heart Study Community-Based Cohort.
    Staerk L; Preis SR; Lin H; Casas JP; Lunetta K; Weng LC; Anderson CD; Ellinor PT; Lubitz SA; Benjamin EJ; Trinquart L
    Circ Cardiovasc Qual Outcomes; 2020 Apr; 13(4):e005918. PubMed ID: 32228064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.
    Alonso A; Krijthe BP; Aspelund T; Stepas KA; Pencina MJ; Moser CB; Sinner MF; Sotoodehnia N; Fontes JD; Janssens AC; Kronmal RA; Magnani JW; Witteman JC; Chamberlain AM; Lubitz SA; Schnabel RB; Agarwal SK; McManus DD; Ellinor PT; Larson MG; Burke GL; Launer LJ; Hofman A; Levy D; Gottdiener JS; Kääb S; Couper D; Harris TB; Soliman EZ; Stricker BH; Gudnason V; Heckbert SR; Benjamin EJ
    J Am Heart Assoc; 2013 Mar; 2(2):e000102. PubMed ID: 23537808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy.
    Okin PM; Bang CN; Wachtell K; Hille DA; Kjeldsen SE; Julius S; Dahlöf B; Devereux RB
    Am J Hypertens; 2014 Jul; 27(7):966-72. PubMed ID: 24552888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.
    Soliman EZ; Lopez F; O'Neal WT; Chen LY; Bengtson L; Zhang ZM; Loehr L; Cushman M; Alonso A
    Circulation; 2015 May; 131(21):1843-50. PubMed ID: 25918127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between eicosanoids and incident atrial fibrillation in the Framingham Heart Study.
    Kornej J; Qadan MA; Alotaibi M; Van Wagoner DR; Watrous JD; Trinquart L; Preis SR; Ko D; Jain M; Benjamin EJ; Cheng S; Lin H
    Sci Rep; 2022 Nov; 12(1):20218. PubMed ID: 36418854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke.
    Tada H; Shiffman D; Smith JG; Sjögren M; Lubitz SA; Ellinor PT; Louie JZ; Catanese JJ; Engström G; Devlin JJ; Kathiresan S; Melander O
    Stroke; 2014 Oct; 45(10):2856-2862. PubMed ID: 25123217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.